Enzymes & Biological Catalysis
Enzymes & Biological Catalysis
Enzymes & Biological Catalysis
uncatalyzed
Moving Object ant crawling person walking race horse gallop Bugatti Veyron FA-22 Raptor Space shuttle Photon from sun Speed (mph) 0.06 3 40 253 1500 17,500 6.7 x 108
catalyzed
Rate Increase 1 101.6 102.9 103.7 104.4 105.5 108.8
acetaldehyde
B
O
OH
A E
-OOC
oxaloacetate
COO-
COO-
NAD+ NADH
O
CoASH CO2
lactate
COO-
acetyl-CoA
SCoA
ADP Pi
COO-
HCO3ATP
oxaloacetate
COO-
SCoA
acetyl-CoA
OH
-OOC
COOCOO-
citrate
Enzyme Classes
Cofactors
Mg2+ Zn2+ Cu2+ Fe3+ Ca2+ bind enzyme transiently stably bound to enzyme
Vitamin-derived Coenzymes
[B] K eq = [A]
A B
G = RT lnK eq
A quantitative measure of the tendency of a reaction
28
Mix A, B
Measure A, B
G > 0, reaction unfavored (endergonic) G < 0, reaction favored (exergonic) G = 0, reaction at equilibrium
G 0
-28 10-5 1 105
Keq
Effect of Enzymes
GB contributes to specificity and catalysis. Weak interactions between E and S are optimized at the transition state.
Active sites shape is complementary to the geometry of the reaction transition state.
Formation of ES Complexes
Lock-and-key model
Induced-fit model
Acceleration due to reduction in energy needed to reach transition state NO effect on Keq
Favorable weak interactions between E and S promote ES, lower transition state energy
Maximal interactions between E and S occur when S assumes the shape of the transition state
Enzyme Kinetics
(when Km = [S])
kcat = maximum number of molecules of substrate that can be converted to product per second per active site
kcat[ET][S] Vo = Km + [S]
Specificity Constant: kcat/Km Under physiologic conditions, most enzymes operate at [S]:Km = 0.01-1.0.
If Km >> [S], then Specificity constant measures speed of enzyme when [S] low.
Index of efficiency of intermolecular collisions.
Diffusion controlled reactions have k~108 .
Enzyme Inhibition
Various agents block enzyme activity
Ibuprofen
O
OH
Types of Inhibition
Irreversible inhibitors Reversible inhibitors Competitive Uncompetitive Noncompetitive
Form irreversible complex with E, mechanism-based inactivators
(aka, noncompetitive)
Competitive Inhibition
v0 =
= 1+
[I] KI
Uncompetitive Inhibition
Vmax [S] v0 = K M + a [S] [I] = 1+ KI
Table 12-2
Effect of Ibuprofen on PGG2 [S] 0.5 1.0 1.5 2.5 3.5 Vo 23.5 32.2 36.9 41.8 44.0 +IB 16.67 25.25 30.49 37.04 38.91 1/[S] 2 1 0.67 0.40 0.286 1/Vo 0.043 0.031 0.027 0.024 0.023 +IB 0.06 0.04 0.033 0.027 0.026
Catalytic Strategies
Promote favorable geometric configuration and proximity of substrates Guiding principles Enhance partial charges on reactive species Stabilize transition states Stabilize charged reaction intermediates
glyceraldehyde-3-phosphate NAD+, Pi
NADH
O P -O OOH O O OO O P O-
1,3-diphosphoglycerate
O R' O
O R' O O C R HO R' H
O C R
C + R
H H
OH
Electrostatic Effects
A xed charge or polar group can stabilize the transition state.
Positive charged moiety can stabilize transient negative charges.
O C R1 O R2 R1 O H O H R3 O C O R3
NH3 OC O R2
Structural Flexibility
Substrate binding often induces conformational change in enzyme. Overall effects:
Examples
Hexokinase
Glc + ATPGlc-6P + ADP
Chymotrypsin
HK
HK + Glc
Serine Proteases
Large family of hydrolases with diverse functions
O O N+ H2O
acetylcholine
acetylcholinesterase
O OHO N+
acetate
choline
Asp O OH N N H O Ser
Trypsin
Specificity Pocket
Zymogens
Proteolytic enzymes usually synthesized as inactive precursors Zymogenic form prevents active proteases from digesting tissues that synthesize them